Literature DB >> 18459985

Primary esophageal repair in Boerhaave's syndrome.

Sukki Cho1, Sanghoon Jheon, Kyung-Min Ryu, Eung Bae Lee.   

Abstract

Boerhaave's syndrome is the most severe disease in the esophageal perforation. The purpose of this report is to evaluate the outcome in patients who were treated with primary repair for Boerhaave's syndrome regardless of the time interval. From 1997 to July 2007, 10 patients with Boerhaave's syndrome were treated with primary repair regardless of the time interval. The interval between rupture and initial treatment was less than 24 hours in five patients (50.0%) and more than 24 hours in the other five patients (50.0%). There was no operative mortality and five postoperative leaks. Of these five patients with postoperative leaks, one received primary repair for less than 24 hours (20%) and four received operation for more than 24 hours (80%). However, postoperative leaks were managed by non-operative methods and resolved within 2 weeks. The time interval between perforation and operative intervention should not prejudice the surgeon against primary repair of Boerhaave's syndrome. Although a high incidence of postoperative leak occurred in patients who were operated on for more than 24 hours, its management is not hard to perform and its prognosis was not poor.

Entities:  

Mesh:

Year:  2008        PMID: 18459985     DOI: 10.1111/j.1442-2050.2008.00833.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  13 in total

1.  Thoracoscopic esophageal repair with barbed suture material in a case of Boerhaave's syndrome.

Authors:  Toru Nakano; Chiaki Sato; Tadashi Sakurai; Kurodo Kamiya; Takashi Kamei; Noriaki Ohuchi
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Recurrent spontaneous esophageal rupture.

Authors:  Keisuke Ieta; Akira Oki; Katsunobu Teshigahara; Katsuya Osone; Shigeru Sasaki; Junichi Nakamura; Koji Nakagawa; Hiroyuki Kuwano
Journal:  Clin J Gastroenterol       Date:  2013-01-03

3.  A late diagnosed case of Spontaneous esophageal perforation in an elderly patient.

Authors:  Lu Wei; Fei Wang; Shuyan Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 4.  Current treatment and outcome of esophageal perforations in adults: systematic review and meta-analysis of 75 studies.

Authors:  Fausto Biancari; Vito D'Andrea; Rosalba Paone; Carlo Di Marco; Grazia Savino; Vesa Koivukangas; Juha Saarnio; Ersilia Lucenteforte
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

5.  Boerhaave's syndrome during bowel preparation with polyethylene glycol in a patient with postpolypectomy bleeding.

Authors:  Ji-Youn Yu; Seung-Kyoung Kim; Eun-Chul Jang; Ju-Ok Yeom; Sun-Young Kim; Young-Seok Cho
Journal:  World J Gastrointest Endosc       Date:  2013-05-16

6.  Surgical treatment of esophageal perforations: the importance of a primary repair.

Authors:  L Sulpice; M Rayar; B Laviolle; D Cunin; A Merdrignac; K Boudjema; Bernard Meunier
Journal:  Surg Today       Date:  2012-09-18       Impact factor: 2.549

7.  Management of esophageal perforation in 120 consecutive patients: clinical impact of a structured treatment algorithm.

Authors:  Joerg Lindenmann; Veronika Matzi; Nicole Neuboeck; Udo Anegg; Alfred Maier; Josef Smolle; Freyja Maria Smolle-Juettner
Journal:  J Gastrointest Surg       Date:  2013-04-05       Impact factor: 3.452

8.  Internal Drainage of an Esophageal Perforation in a Patient with a High Surgical Risk.

Authors:  Hongsun Kim; Younghwan Kim; Jong Ho Cho; Yang Won Min
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2017-10-05

9.  Thoracoscopic primary repair with mediastinal drainage is a viable option for patients with Boerhaave's syndrome.

Authors:  Toru Nakano; Ko Onodera; Hirofumi Ichikawa; Takashi Kamei; Yusuke Taniyama; Tadashi Sakurai; Go Miyata
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

10.  The Role of Operation in the Treatment of Boerhaave's Syndrome.

Authors:  Dingpei Han; Zhuoqiong Huang; Jie Xiang; Hecheng Li; Junbiao Hang
Journal:  Biomed Res Int       Date:  2018-06-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.